scPharmaceuticals Inc. (NASDAQ: SCPH)
$3.3500
-0.0700 ( -5.37% ) 191.0K
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
Market Data
Open
$3.3500
Previous close
$3.4200
Volume
191.0K
Market cap
$167.63M
Day range
$3.2700 - $3.9950
52 week range
$3.0750 - $6.5400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q/a | Quarterly Reports | 18 | Dec 31, 2024 |
8-k | 8K-related | 13 | Dec 11, 2024 |
8-k | 8K-related | 15 | Nov 13, 2024 |
10-q | Quarterly Reports | 70 | Nov 13, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4/a | Other | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 15, 2024 |
8-k | 8K-related | 14 | Aug 14, 2024 |
10-q | Quarterly Reports | 71 | Aug 14, 2024 |
8-k | 8K-related | 18 | Aug 13, 2024 |